26 May 2013
Keywords: study, procrit, cheaper, rival, anemia, drugs, usa-based
Article | 06 November 2006
USA-based Ortho Biotech Products, a Johnson & Johnson company, says that the results of a large retrospective analysis suggest that Procrit
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 November 2006
24 May 2013
© 2013 thepharmaletter.com